What is CCEL's current stock price?

CCEL (Cryo-Cell International, Inc.) is currently trading at $3.46 with a market cap of $27.9M.

What sector is Cryo-Cell International, Inc. in?

Cryo-Cell International, Inc. (CCEL) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.

Is CCEL a good stock to buy?

Analysts have a Hold consensus on CCEL with a price target of $8.50. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

CCEL Cryo-Cell International, Inc.

Healthcare

$3.46+0.58%ClosedMarket Cap: $27.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-1.51

P/S

0.89

EV/EBITDA

-2294.48

DCF Value

$-8.71

FCF Yield

17.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

77.5%

Operating Margin

0.6%

Net Margin

-8.5%

ROE

15.8%

ROA

-4.4%

ROIC

0.4%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$7.7M	$47.1K	$—
Q4 null	$7.8M	$-4.7M	$—
FY null	$31.6M	$-2.4M	$—
Q3 null	$7.8M	$1.6M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$8.50

Target (Median)

$8.50

Target Range

$8.50 - $8.50

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Maxim GroupHold

2025-10-20

Trading Activity

Insider Trades

View All

TAYMANS JILL Mofficer: VP Finance, CFO

SellFri Jan 09

TAYMANS JILL Mofficer: VP Finance, CFO

SellFri Jan 09

Portnoy Mark L.director, 10 percent owner, officer: Co-CEO

SellFri Jan 09

Portnoy Mark L.director, 10 percent owner, officer: Co-CEO

SellFri Jan 09

PORTNOY DAVIDdirector, 10 percent owner, officer: Chairman, Co-CEO

SellFri Jan 09

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

Exchange

—

Beta

0.58

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Peers